Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma.
Hirai Y, Sakurai J, Yoshida S, Kikuchi T, Mitsuhashi T, Miyake T, Fujimura T, Abe R, Fujikawa H, Boki H, Suga H, Shibata S, Miyagaki T, Shimauchi T, Kiyohara E, Kawakami Y, Morizane S.
Hirai Y, et al. Among authors: shimauchi t.
J Dermatol. 2024 Aug;51(8):1037-1049. doi: 10.1111/1346-8138.17324. Epub 2024 Jun 14.
J Dermatol. 2024.
PMID: 38874430
Free PMC article.
Clinical Trial.